Patient Guide: A Phase 2 Study of ABSK043 Combined With Osimertinib

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 7 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07710612
Status: UPCOMING
Condition: Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive
Phase: Phase II

Find a Study Location Near You

This study is available at 7 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Guangzhou, Guangdong
  • Harbin, Heilongjiang
  • Wuhan, Hubei
  • • And 4 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily